Franklin Moser, MD
Neuroradiology · Los Angeles, CANPI 1619000668
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (34.9%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by GE HealthCare at 44.5% of the total. Reporting peaked in 2019 at $17,325 and has fallen 76.3% since, to $4,105 in 2025.
Across 104 payments — averaging $387.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GE HealthCare$18K
- Siemens Medical Solutions USA, Inc.$8K
- Bayer$7K
- Guerbet LLC$4K
- Stryker$2K
- Canon Medical Informatics, Inc.$203
- plus $392 from 4 others
Across 2 payments — averaging $14,385 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bayer$29K
What the payments were for
- Consulting fees$11,09728%
- Speaking & faculty fees$14,04435%
- Travel & lodging$10,77627%
- Food & beverage$4,37611%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GE HealthCare | 17 | $17,947 |
| Siemens Medical Solutions USA, Inc. | 19 | $8,444 |
| Bayer | 10 | $6,942 |
| Guerbet LLC | 5 | $4,086 |
| Stryker | 45 | $2,278 |
| Canon Medical Informatics, Inc. | 2 | $203 |
| Medtronic(2 entities) | 3 | $173 |
| Penumbra, Inc. | 1 | $105 |
| Innocoll Pharmaceuticals Limited | 1 | $94 |
| Telix Pharmaceuticals | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Artis Q$7,796
- Gadavist$6,652
- ELUCIREM$4,086
- CLARISCAN$3,383
- VISIPAQUE$2,047
- SPINEJACK$709
- IVS - VERTEBRAL AUGMENTATION PRODUCTS$632
- VITREA ADVANCED / VITREA CONNECTION$188
- IVAS$145
- OSTEOCOOL RF ABLATION$133
- Artis Q floor$128
- Penumbra System$105
How this compares
$40,294 in reported general payments places this provider in the 85th percentile of 154 neuroradiology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neuroradiology in Los Angeles
- Reza JahanLos Angeles$75K
- Marcel MayaLos Angeles$24K
- Fernando VinuelaLos Angeles$23K
- Noriko SalamonLos Angeles$20K
- Mark ShiroishiLos Angeles$8K
- Eu-Meng LawLos Angeles$2K
- Daniel PhungLos Angeles$2K
- John RheeLos Angeles$867
- Aaron BerezMountain View$24.1M
- Amon LiuRedwood City$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.